Natural Product: NPC17388

Natural Product IDNPC17388
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
N-(3-Methoxybenzyl)Palmitamide
IUPAC Name N-[(3-methoxyphenyl)methyl]hexadecanamide
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL2415103
PubChem CID 71765531
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0002341] Phenol ethers
        • [CHEMONTID:0000138] Anisoles

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey FIQGQTITXPTKIY-UHFFFAOYSA-N
Standard InCHI InChI=1S/C24H41NO2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-19-24(26)25-21-22-17-16-18-23(20-22)27-2/h16-18,20H,3-15,19,21H2,1-2H3,(H,25,26)
SMILES CCCCCCCCCCCCCCCC(=NCc1cccc(c1)OC)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   375.31 Volume:   433.135
?
Van der Waals volume.
Dense:   0.866 LogP:   7.19
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   4.316
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.626
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   17.0 Rigid Bonds:   7.0
TPSA:   41.82
?
Topological Polar Surface Area.
H-Bond Acceptor:   3.0
H-Bond Donor:   1.0 Rings:   1.0
Heavy Atoms:   3.0

MedChem Properties

QED Drug-Likeness Score:   0.173 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.272 Fsp3:   0.708
MCE-18:   6.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.674 Fluc inhibitor:   0.155
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.006
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.462
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.022 Promiscuous compounds:   0.079

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.037 MDCK Permeability:   -4.798
Pgp-inhibitor:   0.028 Pgp-substrate:   0.002
PAMPA:   0.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.805
20% Bioavailability (F20%):   0.858 30% Bioavailability (F30%):   0.95
50% Bioavailability (F50%):   0.435

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.012 MRP1:   0.842
Plasma Protein Binding (PPB):   99.312% Volume Distribution (VD):   1.215
Fu: 0.958%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.867
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.049
BSEP inhibitor:   0.959

ADMET: Metabolism

CYP1A2-inhibitor:   0.059 CYP1A2-substrate:   0.902
CYP2C19-inhibitor:   0.939 CYP2C19-substrate:   0.413
CYP2C9-inhibitor:   0.999 CYP2C9-substrate:   0.866
CYP2D6-inhibitor:   0.999 CYP2D6-substrate:   0.133
CYP3A4-inhibitor:   0.112 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.99 CYP2C8-inhibitor:   0.963
HLM stability:   0.101
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  5.268 Half-life (T1/2):  0.579

ADMET: Toxicity

hERG Blockers:  0.403 hERG Blockers (10um):  0.758
Human Hepatotoxicity (H-HT):  0.911 Drug-induced Liver Injury (DILI):  0.825
AMES Toxicity:  0.435 Rat Oral Acute Toxicity:  0.134
Maximum Recommended Daily Dose:  0.571 Skin Sensitization:  0.999
Carcinogencity:  0.855 Eye Corrosion:  0.01
Eye Irritation:  0.944 Respiratory Toxicity:  0.966
Drug-induced Neurotoxicity:  0.228 Ototoxicity:  0.292
Hematotoxicity:  0.368 Drug-induced Nephrotoxicity:  0.733
Genotoxicity:  0.0 RPMI-8226 Immunitoxicity:  0.011
A549 Cytotoxicity:  0.082 Hek293 Cytotoxicity:  0.114
BCF:   1.331
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   5.248
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.485
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   6.298
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO18988 Lepidium meyenii Species Brassicaceae Eukaryota n.a. n.a. n.a. PMID[12932133]
NPO18988 Lepidium meyenii Species Brassicaceae Eukaryota n.a. n.a. n.a. PMID[23891163]
NPO18988 Lepidium meyenii Species Brassicaceae Eukaryota n.a. n.a. n.a. PMID[24972328]
NPO18988 Lepidium meyenii Species Brassicaceae Eukaryota n.a. n.a. n.a. PMID[33320645]
NPO18988 Lepidium meyenii Species Brassicaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO18988 Lepidium meyenii Species Brassicaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1418 Individual protein Anandamide amidohydrolase Homo sapiens Inhibition = 40.0 % PMID[16933872]
NPT1418 Individual protein Anandamide amidohydrolase Homo sapiens Inhibition = 70.1 % PMID[9090869]
NPT862 Individual protein Epoxide hydratase Homo sapiens IC50 = 235.0 nM PMID[33320645]
NPT21303 Single protein Epoxide hydratase Mus musculus IC50 = 159.0 nM PMID[33320645]
NPT5882 Individual protein Epoxide hydrolase 2 Rattus norvegicus IC50 = 113.0 nM PMID[33320645]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC17388 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC471308
1.0 High Similarity NPC483618
0.8723 High Similarity NPC53596
0.82 Intermediate Similarity NPC289330
0.7647 Intermediate Similarity NPC483619
0.75 Intermediate Similarity NPC160120
0.7308 Intermediate Similarity NPC471314
0.7234 Intermediate Similarity NPC74427
0.7115 Intermediate Similarity NPC471315
0.7115 Intermediate Similarity NPC483620
0.6591 Remote Similarity NPC471307
0.6591 Remote Similarity NPC78041
0.6591 Remote Similarity NPC141139
0.6346 Remote Similarity NPC285078
0.6346 Remote Similarity NPC130595
0.6346 Remote Similarity NPC93882
0.6346 Remote Similarity NPC255540
0.6071 Remote Similarity NPC483621
0.58 Remote Similarity NPC74936
0.58 Remote Similarity NPC159178
0.569 Remote Similarity NPC6854
0.5517 Remote Similarity NPC483622
0.5472 Remote Similarity NPC209764
0.5439 Remote Similarity NPC218530
0.5254 Remote Similarity NPC202613

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC17388 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.6346 Remote Similarity NPD2674 Phase 3
0.5484 Remote Similarity NPD7153 Discontinued

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data